Recent deal
⸱ 11-11-2025
Lexence advised Alfasan on joint venture with Interchemie.
In September 2025, Alfasan (Netherlands) and OÜ Eesti Farmaatsia Grupp (EFG) (Estonia) entered into a joint venture with Interchemie (Netherlands), combining the strengths of Interchemie Group (a porfolio company of Nimbus) and Kepro/Pharmapark Group.
This partnership aims to leverage the complementary expertise and resources of all parties, strengthening their joint position in the veterinary pharmaceutical sector in Europe and beyond.
This joint venture represents an important step in the strategic development of both groups and creates new opportunities for expansion and cooperation in key markets.
The team at lexence consisted of: Mathijs van Doormalen, Rutger Aleva and Jacob Goeman Borgesius
Expertise
